Niki BioSolutions, Inc. vs Cessatech A/S
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Niki BioSolutions, Inc. is the larger company by market value: $6 M against $4 M for Cessatech A/S, 1.5 times as much (market caps of Mar 8, 2026 for Niki BioSolutions, Inc. and Jul 30, 2023 for Cessatech A/S). Niki BioSolutions, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet. Cessatech A/S's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Niki BioSolutions, Inc. NIKI | Cessatech A/S 8GN.F |
|---|---|---|
| Profile | ||
| Country | 🇬🇧 UK | 🇩🇰 Denmark |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Net income | $-1 M | — |
| Profitability | ||
| Return on equity | -6.2% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Mar 2026; ratios FY2025 | Market cap Jul 2023 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Niki BioSolutions, Inc. or Cessatech A/S?
Niki BioSolutions, Inc. is the larger company by market value: $6 M against $4 M for Cessatech A/S, 1.5 times as much (market caps of Mar 8, 2026 for Niki BioSolutions, Inc. and Jul 30, 2023 for Cessatech A/S). Niki BioSolutions, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet. Cessatech A/S's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
More about Niki BioSolutions, Inc.
More about Cessatech A/S
Sources#
Every figure on this page comes from these, with the date shown next to it.